Evaluation of Doppler Flow From the Femoral Artery as a Reflection of Cardiac Flow in a Vascular Fluid Test
RER D
1 other identifier
observational
140
1 country
1
Brief Summary
In order to identify the responding patients with vascular filling test, this research aims to compare the performance of the increased flow in the femoral artery to the performance of the blood pressure increase. The reference measurement will increase cardiac output measured by ultrasound.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 22, 2016
CompletedFirst Posted
Study publicly available on registry
August 25, 2016
CompletedAugust 25, 2016
August 1, 2016
1.9 years
August 22, 2016
August 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
In the intensive care patient of acute circulatory failure signs, assess the increase of the femoral arterial flow (specifically its full-time speed, ΔRVAFitv measured by Doppler ultrasound) to identify responders this fluid replacement.
First patient enrollment: april 2014 - Study duration: 24 month - Patient follow-up: 30 minutes
Interventions
Eligibility Criteria
One hundred and twenty adult patients hospitalized in one of the participating ICUs, will be included (see the justification required number of subjects in "statistics") if * They are already carrying an intra-arterial catheter (femoral or radial). * They exhibit acute circulatory failure signs (see below) * The doctor in charge prescribed a vascular fluid replacement, regardless of the purposes of the study: * vascular fluid replacement * initiation or catecholamine * or increase (\> 10%) of catecholamine dosage.
You may qualify if:
- Patient hospitalized in intensive care and affiliated to a social security system
- Intra-arterial catheter already in place and operational
- Stability blood pressure for 5 min (no change in mean arterial pressure\> 10%, no increase in dose catecholamine)
- Presence of at least one sign of acute circulatory failure from:
- Low blood pressure (mean arterial pressure \<65 mmHg and / or systolic \<90 mmHg)
- tachycardia\> 120 bpm without other obvious cause a circulatory failure
- Oliguria \<1 ml / kg during the last hour suggestive of circulatory failure
- blood Hyperlactataemia\> 2 mmol / l without other obvious cause a systemic circulatory failure (lactate will not be measured for the purposes of the study)
- Smear
- ongoing catecholamine Administration
- Another sign justifying, according to the doctor in charge, vascular filling test (capillary refill time elongated, others ...)
- The doctor in charge has prescribed a fluid loading test, regardless of the needs of the study.
- Clear contraindication to the femoral artery Doppler (wound or burn the groin, for example)
- Complete occlusion of the femoral artery or 2 of the aorta requiring or having required a vascular bypass
- Pregnant woman
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nantes
Nantes, 44000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2016
First Posted
August 25, 2016
Study Start
April 1, 2014
Primary Completion
March 1, 2016
Last Updated
August 25, 2016
Record last verified: 2016-08